Related Experiment Video
Updated: Jul 9, 2026
07:10
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial
1Gastroenterology Unit, Hospital Clinic i Provincial Medical School, Barcelona, Spain.
Gastroenterology
|November 1, 1993
Summary
Endoscopic sclerotherapy reduced rebleeding probability in cirrhotic patients compared to propranolol. However, sclerotherapy caused more severe complications, limiting its long-term use for variceal bleeding prevention.
Area of Science:
- Gastroenterology
- Hepatology
- Interventional Endoscopy
Background:
- Sclerotherapy is a recommended treatment for preventing variceal rebleeding.
- Cirrhotic patients experiencing variceal bleeding require effective long-term management strategies.
Purpose of the Study:
- To compare the efficacy of endoscopic sclerotherapy versus long-term propranolol administration.
- To evaluate the prevention of rebleeding and long-term survival in patients with a history of variceal bleeding.
Main Methods:
- 116 cirrhotic patients with variceal bleeding were randomized.
- Group 1: Propranolol to reduce resting heart rate by 25%.
- Group 2: Weekly intravariceal sclerotherapy until varices disappeared.
Main Results:
- Sclerotherapy group had a lower actuarial probability of rebleeding (P=0.02).
- Rebleeding occurred in 26 sclerotherapy patients vs. 37 propranolol patients.
- No significant differences in survival or causes of death were observed.
Conclusions:
- Sclerotherapy is more effective in reducing rebleeding probability than propranolol.
- Sclerotherapy complications were more frequent and severe, potentially limiting its elective use.
- Neither treatment demonstrated a benefit on other efficacy parameters beyond rebleeding rates.
Related Concept Videos
01:24Esophageal Varices-I: Introduction
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...